Helena Escolà, Beatriz Llombart, Alba Escolà-Rodríguez, Lucía Barchino-Ortiz, Joaquim Marcoval, Inmaculada Alcaraz, Sònia Beà-Ardébol, Agustí Toll, Román Miñano-Medrano, Pedro Rodríguez-Jiménez, María López-Nuñez, Carla Ferrándiz-Pulido, Ane Jaka, Emili Masferrer, Rafael S Aguayo-Ortiz, Mireia Yébenes, Jorge Arandes-Marcocci, Verónica Ruiz-Salas, Lucía Turrión-Merino, Miquel Just, Júlia Sánchez-Schmidt, Lorena Leal, Fátima Mayo-Martínez, Lara Haya-Martínez, Alejandra Sandoval-Clavijo, Giulia Greta Dradi, Yolanda Delgado, Júlia Verdaguer-Faja, Daniel López-Castillo, Ramon M Pujol, Gustavo Deza
BACKGROUND: Topical imiquimod has shown to be an effective treatment for EMPD, although available evidence supporting its use is based on case reports and small series of patients. OBJECTIVES: To investigate the therapeutic outcomes and analyze potential clinico-pathological factors associated with imiquimod response in a large cohort of EMPD patients. METHODS: Retrospective chart review of 125 EMPD patients treated with imiquimod at 20 Spanish tertiary-care hospitals...
March 26, 2024: Clinical and Experimental Dermatology